A Columbia Surgeon’s Study Was Pulled. He Kept Publishing Flawed Data.
The quiet withdrawal of a 2021 cancer study by Dr. Sam Yoon highlights scientific publishers’ lack of transparency around data problems.
By Benjamin Mueller
The quiet withdrawal of a 2021 cancer study by Dr. Sam Yoon highlights scientific publishers’ lack of transparency around data problems.
By Benjamin Mueller
Scientists are raising questions about the ethics of studies backed by Chinese surveillance agencies. Prestigious journals are taking action.
By Sui-Lee Wee and Paul Mozur
The New York Times and Lexis/Nexis are among the companies that are compensating writers for the digital use of their printed articles.
By Jaclyn Peiser
Technology that allows the police to analyze and share data helps prevent crime. But those sophisticated tools may put civil liberties in danger, too.
By Quentin Hardy
David Ruth of the Elsevier Foundation writes about the need to retain our female STEM work force.
Once a must-read, Variety has been declining as the type of news it provides proliferates on the Web, for free. In addition, studios, also battling financial obstacles, have cut down on trade ads.
By Brooks Barnes and Michael Cieply
Advocates and opponents of “open access” for government-financed scientific research are girding for a long battle before Congress, which has little enthusiasm for either extreme.
By Guy Gugliotta
Also, the academic boycott of the publisher Elsevier grows and how a model vaulted herself onto the cover of the Sports Illustrated swimsuit issue.
By Noam Cohen
More than 5,700 researchers are denouncing the pricing policies of the journal publisher Elsevier in a growing furor over open access to the fruits of scientific research.
By Thomas Lin
Many scientists want to open up an age-old system of submitting private research to commercial journals that they say is hidebound, expensive and elitist.
By Thomas Lin
Advertisement
Advertisement